Prof. Dr. Falk Nimmerjahn

Lehrstuhl für Genetik

Steigerung der zytotoxischen Aktivitat eines CD19 Antikorpers durch duale Fc-Optimierung (2022) Gehlert CL, Rahmati P, Boje AS, Winterberg D, Krohn S, Theocharis T, Nimmerjahn F, et al. Conference contribution Enhancement of CD38 antibody-mediated phagocytosis of TALL cells by Fc engineering and CD47 blockade (2022) Hilger P, Zeller T, Vogiatzi F, Mueller K, Muennich IA, Windisch R, Wichmann C, et al. Conference contribution Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody (2022) Gehlert CL, Rahmati P, Boje AS, Winterberg D, Krohn S, Theocharis T, Cappuzzello E, et al. Journal article Response to Oswald et al.: ST6Gal1 in plasma is dispensable for IgG sialylation (2022) Werner A, Nimmerjahn F Journal article, Letter HINGEneering IgG for enhanced immune activation (2022) Werner A, Nimmerjahn F Journal article, Review article Determining immunoglobulin-specific B cell receptor repertoire of murine splenocytes by next-generation sequencing (2022) Werner A, Schäfer S, Gleußner N, Nimmerjahn F, Winkler T Journal article Low-dose Radiotherapy with X-rays and Radon leads to different immunological Changes in a Mouse Model for Rheumatoid Arthritis (2022) Deloch L, Rückert M, Maier A, Hinrichs A, Weissmann T, Seeling M, Nimmerjahn F, et al. Conference contribution Unraveling the Arthus Mystery: Fc Receptors and the Holy Grail of Inflammation (2022) Nimmerjahn F, Cooper MD Journal article Zooming in on dendritic cells for CD40 agonists (2022) Hübner J, Nimmerjahn F Journal article Possible functional impact of IgG3 allotype constant region (2022) Kallolimath S, Nimmerjahn F, Steinkellner H Journal article